Emad Babakhanzadeh
Overview
Explore the profile of Emad Babakhanzadeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nazari M, Babakhanzadeh E, Mollazadeh A, Ahmadzade M, Mohammadi Soleimani E, Hajimaqsoudi E
Cancer Cell Int
. 2024 Dec;
24(1):415.
PMID: 39702144
The long non-coding RNA HOTAIR is overexpressed in many cancers and is associated with several cancer-promoting effects, including increased cell proliferation, migration and treatment resistance. HOTAIR levels correlate with tumor...
2.
Babakhanzadeh E, Hoseininasab F, Khodadadian A, Nazari M, Hajati R, Ghafouri-Fard S
Hereditas
. 2024 Nov;
161(1):46.
PMID: 39551760
Infertility is a global problem being associated with emotional and financial burden. Recent studies have shown contribution of a group of non-coding RNAs, namely circular RNAs (circRNAs) to the etiology...
3.
Ashkezari F, Mirabutalebi S, Babakhanzadeh E, Ghasemi N
Mol Biol Rep
. 2024 Nov;
51(1):1148.
PMID: 39535657
Background: Endometriosis is a benign gynecological disease that affects about 1% of all women and up to 15% of women of childbearing age. To date, none of the proposed theories...
4.
Jahangir M, Nazari M, Babakhanzadeh E, Manshadi S
BMC Med Genomics
. 2024 May;
17(1):128.
PMID: 38730451
The parallel rise in obesity and male infertility in modern societies necessitates the identification of susceptibility genes underlying these interconnected health issues. In our study, we conducted a comprehensive search...
5.
Huang C, Sarafraz P, Enayati P, Mortazavi Mamaghani E, Babakhanzadeh E, Nazari M
Cancer Cell Int
. 2024 Jan;
24(1):40.
PMID: 38238742
No abstract available.
6.
Hoseini S, Enayati P, Nazari M, Babakhanzadeh E, Rastgoo M, Sohrabi N
J Gastrointest Cancer
. 2024 Jan;
55(2):497-510.
PMID: 38168859
Objective: Breakthroughs in omics technology have led to a deeper understanding of the fundamental molecular changes that play a critical role in the development and progression of cancer. This review...
7.
Huang C, Esfani Sarafraz P, Enayati P, Mortazavi Mamaghani E, Babakhanzadeh E, Nazari M
Cancer Cell Int
. 2023 Nov;
23(1):288.
PMID: 37993909
CircRNAs, a special type of noncoding RNAs characterized by their stable structure and unique abilities to form backsplicing loops, have recently attracted the interest of scientists. These RNAs are abundant...
8.
Babakhanzadeh E, Danaei H, Abedinzadeh M, Ashrafzadeh H, Ghasemi N
Int J Reprod Biomed
. 2021 Sep;
19(8):725-732.
PMID: 34568733
Background: Recurrent pregnancy loss (RPL) is the most common complaint of pregnancy in females with a prevalence of 5%. Numerous documents have shown that single nucleotide polymorphisms are able to...
9.
Khodadadian A, Varghaiyan Y, Babakhanzadeh E, Alipourfard I, Haghi-Daredeh S, Ghobadi A, et al.
Int J Reprod Biomed
. 2021 Mar;
19(2):157-166.
PMID: 33718760
Background: Surgery and chemotherapy are the two most common treatments for cancers, including ovarian cancer. Although most ovarian cancers occur over the age of 45 yr, it may involve younger...
10.
Khodadadian A, Darzi S, Haghi-Daredeh S, Eshaghi F, Babakhanzadeh E, Mirabutalebi S, et al.
Int J Gen Med
. 2020 Sep;
13:627-640.
PMID: 32982380
In a clinical trial, people with the same disease can show different responses after treatment with the same drug and exactly under the same conditions. Some of them may improve,...